SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Press Releases
Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with Two Active Phase 2 Clinical Trials
March 25, 2026
 · 
11 min read
Press Releases
TempraMed Strengthens Global Intellectual Property Position with Granted Chinese Patent for Newest Product, VIVI Box
March 24, 2026
 · 
1 min read
Press Releases
Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing
March 24, 2026
 · 
1 min read
Press Releases
Envoy Medical Reports Full Year 2025 Financial Results
March 23, 2026
 · 
16 min read
Press Releases
Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement
March 23, 2026
 · 
5 min read
Press Releases
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer’s Disease Program
March 23, 2026
 · 
7 min read
Press Releases
Defence Therapeutics Announces Warrant Terms Amendment
March 20, 2026
 · 
3 min read
Press Releases
Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204
March 18, 2026
 · 
5 min read
Press Releases
MCI Capital Markets and AxialBridge to Deliver Integrated De-Risking and Capital Access Platform for Life Science Companies
March 18, 2026
 · 
4 min read
Press Releases
Resverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&A
March 18, 2026
 · 
4 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us